Research reportCardiovascular regulatory actions of the hypocretins in brain
Introduction
Using directional tag PCR subtraction techniques, Gautvik et al. [6] identified multiple rat mRNAs that were selectively expressed in hypothalamus. Recently, this same group [2] reported that one of the clones encodes a precursor peptide which could be post translationally modified to result in the production of two biologically active peptides. They termed these peptides the hypocretins, because of their hypothalamic localization and their structural homology to the gut hormone secretin. Furthermore, de Lecea et al. [2] also demonstrated the sites of production of the hypocretins in brain, the projection fields of the cells producing the peptides and, importantly, direct neural effects of one of the peptides, hypocretin-2. They suggested that the hypocretins might play important roles in a variety of hypothalamic functions including the control of food intake and blood pressure regulation. These hypotheses were supported by subsequent work which demonstrated projections to cardiovascular centers in brain [10] and direct neural effects [16] of both hypocretin-1 (Hcrt-1) and hypocretin-2 (Hcrt-2).
Another group [12], using cell based reporter strategies to discover novel, orphan receptor ligands, reported the discovery of gene products similar to the hypocretins. This group termed these peptides orexins, because of their observations that when injected in vivo they stimulated food intake. They had correctly anticipated these orexogenic activities on the basis of their orexin peptide and orexin receptor localization studies.
Because nerve fibers containing immunoreactive hypocretin/orexin (henceforth identified as hypocretin) have been reported to project [2] not only to hypothalamic feeding centers in the lateral and medial hypothalamus, but also to other limbic regions of the diencephalon and, importantly, to cardiovascular regulatory centers in the hindbrain, we hypothesized that additional biologic activities other than orexogenesis existed in brain. Specifically, hypocretin-immunopositive neuronal projections predicted effects on the central regulation of cardiovascular function. We studied, therefore, the effects of intracerebroventricular (i.c.v.) administration of Hcrt-1 and Hcrt-2 on mean arterial blood pressure in conscious, unrestrained rats. We report here significant actions of the peptides on mean arterial blood pressure at doses which are minimally orexogenic, suggesting broader physiologic potential than merely stimulation of food intake in the rat.
Section snippets
Materials and methods
Amidated Hypocretin-1 (human, mouse, rat orexin A; EPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2), amidated Hypocretin-2 (mouse, rat orexin B; RPGPPGLQRLQRLLQANGNHAAGILTM-NH2), and angiotensin II (A II) were obtained from Phoenix Pharmaceuticals (Mt. View, CA) and diluted in physiologic saline (0.9% NaCl). Adult male rats (200–250 g, Sprague–Dawley, Harlan, Indianapolis, IN) were housed individually (lights on 0500 h, off 1900 h) following implantation of a chronic indwelling cannula (23 gauge,
Results
Both doses (1 and 5 nmol) of Hcrt-1 significantly stimulated food intake at 60 min (p<0.05) in ad libitum fed rats (Fig. 1). Food intakes did not differ between the three treatment groups at 120 and 180 min and there were no significant differences in food intake between animals at any sampling point in the 1 nmol and the 5 nmol Hcrt-1 treated groups.
Intracerebroventricular administration of 1 nmol Hcrt-1 resulted in significant elevation of arterial blood pressure in conscious rats (Fig. 2,
Discussion
Much attention has been focused recently on the roles played by neuropeptides in the control of food intake and body composition 1, 3, 4, 5, 7, 8, 9, 11, 15. Indeed both stimulatory and inhibitory peptides have been identified and characterized and the importance of genetic models of altered peptide or receptor function established. Neuropeptide Y and galanin remain the most potent orexogenic agents identified; however, recently an additional family of peptides was identified independently by
Acknowledgements
These studies were conducted with funding from the Neuropsychiatric Research Institute of Fargo and the Max Baer Heart Fund (Fraternal Order of Eagles).
References (17)
- et al.
Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide
Eur. J. Pharmacol.
(1986) - et al.
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
Cell
(1998) - et al.
Distribution of orexin receptor mRNA in the rat brain
FEBS Lett.
(1998) - et al.
Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism
Am. J. Physiol.
(1994) - et al.
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
Proc. Natl. Acad. Sci. U.S.A.
(1998) - et al.
Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
Science
(1996) - et al.
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Nature
(1997) The alphabet of weight control
Science
(1997)